SourcesWeb search

Products 31 to 40 of 130

Biotech components: Animal
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (5 years ago)
Date last modified: 2018/11/19 09:38 (5 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Gene Editing
Business models: B2C
Country of production: Switzerland
Country of distribution: Switzerland
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:47 (5 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Chip[s] Board by Chip[s] Board
Biotech components: Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (5 years ago)
Date last modified: 2018/11/19 09:36 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial + Multipurpose
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction + Design + Other
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 years ago)
Date last modified: 2020/12/18 14:39 (3 years ago)
Known funding amount: 50,000,000 USD
Funding types: Private Funding
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
CRISPR-Cas9 by CRISPR
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: Research
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 13:59 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: CRSP (NASDAQ)
Value chain stage: Finished Product
CRISPR/Cas9 Application in Poplar Trees by VIB (the Flanders Institute for Biotechnology)
Biotech components: Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:35 (3 years ago)
Date last modified: 2020/12/18 14:35 (3 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Industrial
Market status: Early Stage Concept + More information needed
Organization type(s): Research Institution
Product categories: Construction + Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input + Platform
CropOS by Benson Hill Biosystems
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA + Spain + Brazil
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/06/21 16:07 (5 years ago)
Known funding amount: 34,700,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
crPhage by Locus Biosciences
Biotech components: Gene Editing + Molecule + Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (5 years ago)
Date last modified: 2019/09/12 15:10 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Health + Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
De-extincted hibiscus perfume by Ginkgo Bioworks
Biotech components: Enzyme + Plant + Yeast
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (5 years ago)
Date last modified: 2018/11/19 09:44 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: N/A
Market status: Under Development
Organization type(s): Private Company
Product categories: Personal Care
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Canada + Switzerland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/05/15 15:47 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Open Release
Source: Web search
Trading symbol: BAS (ETR)
Value chain stage: Input